Find Federal Grants
National Institutes of Health · RFA-HG-25-004
National Institutes of Health · RFA-HG-25-003
National Institutes of Health · RFA-HG-25-002
National Institute of Corrections · 25JD07
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-275
High-Assay Low-Enriched Uranium (HALEU) Transportation Package, Inflation Reduction Act (IRA)
Idaho Field Office · DE-FOA-0002967
Bureau of Reclamation · R25AS00016
National Institute of Corrections · 25CS06
American Indian and Alaska Native Head Start Expansion, Early Head Start Expansion, and Early Head Start-Child Care Partnership Grants
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-HI-0066
FY25 National Network Cooperative Agreement to the National Railroad Passenger Corporation
DOT - Federal Railroad Administration · FR-AMT-25-004
FY25 Northeast Corridor Cooperative Agreement to the National Railroad Passenger Corporation
DOT - Federal Railroad Administration · FR-AMT-25-003
Cooperative Agreement for CESU-affiliated Partner with Californian Cooperative Ecosystem Studies Unit
Geological Survey · G25AS00135
U.S. Mission to Slovakia · PAS-SVK-FY2025-01
U.S. Mission to Namibia · WHK-STUDYABROAD-FY25-02
FY2025 NMFS-Sea Grant Fellowship in Population and Ecosystem Dynamics and Marine Resource Economics
DOC NOAA - ERA Production · NOAA-OAR-SG-2025-29114
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-HC-R12-0162
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-YT-R11-0156
Administration for Children and Families - OHS · HHS-2025-ACF-OHS-HC-R11-0161
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
National Institutes of Health · RFA-HL-26-015
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
National Institutes of Health · RFA-HL-26-014